Tammi L Gaskins insider trades: Ironwood Pharmaceuticals (IRWD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tammi reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | IRWD | ↓ Sell | 21,526 | $3.73 | $80K | Direct | Feb 25, 2026 (1d) |
| Nov 17, 2025 | IRWD | ↓ Sell | 6,016 | $3.32 | $20K | Direct | Nov 19, 2025 (2d) |
| Aug 11, 2025 | IRWD | ↓ Sell | 1,316 | $0.84 | $1K | Direct | Aug 13, 2025 (2d) |
| May 16, 2025 | IRWD | ↓ Sell | 2,563 | $0.58 | $1K | Direct | May 20, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRWD insiders
Open-market trades in the last 12 months
About Tammi L Gaskins's insider trades
Tammi L Gaskins is Chief Commercial Officer at Ironwood Pharmaceuticals (IRWD). Since May 16, 2025, Tammi has reported no open-market purchases and 4 sales worth $103K on SEC Form 4. In the last 12 months: 2 sales ($100K).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRWD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.